Belangrijkste bronnen

Dit zijn vooral bronnen voor teksten die niet in standaardleerboeken te vinden zijn.

Hoofdstuk 1

Bandani, A.R.: ‘Effect of Plant a-Amylase Inhibitors on Sunn Pest, Eurygaster Integriceps Puton (Hemiptera: Scutelleridae), Alpha-Amylase Activity’. In: Commun Agric Appl Biol Sci. 2005; 70 (4): p. 869–873.

Baugh, R.F. et al.: ‘Clinical Practice Guideline: Tonsillectomy in Children’. In: Otolaryngol Head Neck Surg. Januari 2011; 144 (Suppl. 1): p. 1–30.

Bengmark, S.: ‘Integrative Medicine and Human Health – The Role of Pre-, Pro- and Synbiotics’. In: Clin Transl Med. 28 mei 2012; 1 (1): p. 6.

Bernardo, D. et al.: ‘Is Gliadin Really Safe for Non-Coeliac Individuals? Production of Interleukin 15 in Biopsy Culture from Non-Coeliac Individuals Challenged with Gliadin Peptides’. In: Gut. Juni 2007; 56 (6): p. 889 f.

Bodinier, M. et al.: ‘Intestinal Translocation Capabilities of Wheat Allergens Using the Caco-2 Cell Line’. In: J Agric Food Chem. 30 mei 2007; 55 (11): p. 4576–4583.

Bollinger, R. et al.: ‘Biofilms in the Large Bowel Suggest an Apparent Function of the Human Vermiform Appendix’. In: J Theor Biol. 21 december 2007; 249 (4): p. 826–831.

Catassi, C. et al.: ‘Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders’. In: Nutrients. 26 september 2013; 5 (10): p. 3839–3853.

Kim, B.H., Gadd, G.M.: Bacterial Physiology and Metabolism. Cambridge: Cambridge University Press, 2008.

Klauser, A.G. et al.: ‘Behavioral Modification of Colonic Function. Can Constipation Be Learned?’ In: Dig Dis Sci. Oktober 1990; 35 (10): p. 1271–1275.

Lammers, K.M. et al.: ‘Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3’. In: Gastroenterology. Juli 2008; 135 (1): p. 194–204.

Ledochowski, M. et al.: ‘Fructose- and Sorbitolol-Reduced Diet Improves Mood and Gastrointestinal Disturbances in Fructose Malabsorbers’. In: Scand J Gastroenterol. Oktober 2000; 35 (10): p. 1048–1052.

Lewis, S.J., Heaton, K.W.: ‘Stool Form Scale as a Useful Guide to Intestinal Transit Time’. In: Scand J Gastroenterol. September 1997; 32 (9): p. 920–924.

Martín-Peláez, S. et al.: ‘Health Effects of Olive Oil Polyphenols: Recent Advances and Possibilities for the Use of Health Claims’. In: Mol. Nutr. Food Res. 2013; 57 (5): p. 760–771.

Paul, S.: Paläopower – Das Wissen der Evolution nutzen für Ernährung, Gesundheit und Genuss. München: C.H. Beck-Verlag, 2013 (2e druk).

Sikirov, D.: ‘Etiology and Pathogenesis of Diverticulosis Coli: A New Approach’. In: Med Hypotheses. Mei 1988; 26 (1): p. 17–20.

Sikirov, D.: ‘Comparison of Straining During Defecation in Three Positions: Results and Implications for Human Health’. In: Dig Dis Sci. Juli 2003; 48 (7): p. 1201–1205.

Thorleifsdottir, R.H. et al.: ‘Improvement of Psoriasis after Tonsillectomy Is Associated with a Decrease in the Frequency of Circulating T Cells That Recognize Streptococcal Determinants and Homologous Skin Determinants’. In: J Immunol. 2012; 188 (10): p. 5160–5165.

Varea, V. et al.: ‘Malabsorption of Carbohydrates and Depression in Children and Adolescents’. In: J Pediatr Gastroenterol Nutr. Mei 2005; 40 (5): p. 561–565.

Wisner, A. et al.: ‘Human Opiorphin, a Natural Antinociceptive Modulator of Opioid-Dependent Pathways’. In: Proc Natl Acad Sci USA. 21 november 2006; 103 (47): p. 17 979–17 984.

Hoofdstuk 2

Agiulera, M. et al.: ‘Stress and Antibiotics Alter Luminal and Walladhered Microbiota and Enhance the Local Expression of Visceral Sensory-Related Systems in Mice’. In: Neurogastroenterol Motil. Augustus 2013; 25 (8): p. e515–e529.

Bercik, P. et al.: ‘The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice’. In: Gastroenterology. Augustus 2011; 141 (2): p. 599–609.

Bravo, J.A. et al.: ‘Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression in a Mouse via the Vagus Nerve’. In: Proc Natl Acad Sci USA. 20 september 2011; 108 (38): p. 16 050–16 055.

Bubenzer, R.H., Kaden, M.: www.sodbrennen-welt.de (opgevraagd in oktober 2013).

Castrén, E.: ‘Neuronal Network Plasticity and Recovery from Depression’. In: JAMA Psychiatry. 2013; 70 (9): p. 983–989.

Craig, A.D.: ‘How Do You Feel – Now? The Anterior Insula and Human Awareness’. In: Nat Rev Neurosci. Januari 2009; 10 (1): p. 59–70.

Enck, P. et al.: ‘Therapy Options in Irritable Bowel Syndrome’. In: Eur J Gastroenterol Hepatol. December 2010; 22 (12): p. 1402–1411.

Furness, J.B. et al.: ‘The Intestine as a Sensory Organ: Neural, Endocrine, and Immune Responses’. In: Am J Physiol Gastrointest Liver Physiol. 1999; 277 (5): p. G922–G928.

Huerta-Franco, M.R. et al.: ‘Effect of Psychological Stress on Gastric Motility Assessed by Electrical Bio-Impedance’. In: World J Gastroenterol. 28 september 2012; 18 (36): p. 5027–5033.

Kell, C.A. et al.: ‘The Sensory Cortical Representation of the Human Penis: Revisiting Somatotopy in the Male Homunculus’. In: J Neurosci. 22 juni 2005; 25 (25): p. 5984–5987.

Keller, J. et al.: ‘S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) zu Definition, Pathophysiologie, Diagnostik und Therapie intestinaler Motilitätsstörungen’. In: Z Gastroenterol. 2011; 49: p. 374–390.

Keywood, C. et al.: ‘A Proof of Concept Study Evaluating the Effect of ADX10059, a Metabotropic Glutamate Receptor-5 Negative Allosteric Modulator, on Acid Exposure and Symptoms in Gastro-Oesophageal Reflux Disease’. In: Gut. September 2009; 58 (9): p. 1192–1199.

Krammer, H. et al.: ‘Tabuthema Obstipation: Welche Rolle spielen Lebensgewohnheiten, Ernährung, Prä- und Probiotika sowie Laxanzien?’ In: Aktuelle Ernährungsmedizin. 2009; 34 (1): p. 38–46.

Layer, P. et al.: ‘S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)’. In: Z Gastroenterol. 2011; 49: p. 237–293.

Ma, X. et al.: ‘Lactobacillus Reuteri Ingestion Prevents Hyperexcitability of Colonic DRG Neurons Induced by Noxious Stimuli’. In: Am J Physiol Gastrointest Liver Physiol. April 2009; 296 (4): p. G868–G875.

Mayer, E.A.: ‘Gut Feelings: The Emerging Biology of Gut-Brain Communication’. In: Nat Rev Neurosci. 13 juli 2011; 12 (8): p. 453–466.

Mayer, E.A. et al.: ‘Brain Imaging Approaches to the Study of Functional GI Disorders: A Rome Working Team Report’. In: Neurogastroenterol Motil. Juni 2009; 21 (6): p. 579–596.

Moser, G. (red.): Psychosomatik in der Gastroenterologie und Hepatologie. Wenen, New York: Springer, 2007.

Naliboff, B.D. et al.: ‘Evidence for Two Distinct Perceptual Alterations in Irritable Bowel Syndrome’. In: Gut. Oktober 1997; 41 (4): p. 505–512.

Palatty, P.L. et al.: ‘Ginger in the Prevention of Nausea and Vomiting: A Review’. In: Crit Rev Food Sci Nutr. 2013; 53 (7): p. 659–669.

Reveiller, M. et al.: ‘Bile Exposure Inhibits Expression of Squamous Differentiation Genes in Human Esophageal Epithelial Cells’. In: Ann Surg. Juni 2012; 255 (6): p. 1113–1120.

Revenstorf, D.: Expertise zur wissenschaftlichen Evidenz der Hypnotherapie. Tübingen, 2003; www.meg-tuebingen.de/downloads/Expertise.pdf (opgevraagd in oktober 2013).

Simons, C.C. et al.: ‘Bowel Movement and Constipation Frequencies and the Risk of Colorectal Cancer Among Men in the Netherlands Cohort Study on Diet and Cancer’. In: Am J Epidemiol. 15 december 2010; 172 (12): p. 1404–1414.

Streitberger, K. et al.: ‘Acupuncture Compared to Placebo-Acupuncture for Postoperative Nausea and Vomiting Prophylaxis: A Randomised Placebo-Controlled Patient and Observer Blind Trial’. In: Anaesthesia. Februari 2004; 59 (2): p. 142–149.

Tillisch, K. et al.: ‘Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity’. In: Gastroenterology. Juni 2013; 144 (7): p. 1394–1401.

Hoofdstuk 3

Aggarwal, J. et al.: ‘Probiotics and their Effects on Metabolic Diseases: An Update’. In: J Clin Diagn Res. Januari 2013; 7 (1): p. 173–177.

Arnold, I.C. et al.: ‘Helicobacter Pylori Infection Prevents Allergic Asthma in Mouse Models through the Induction of Regulatory T Cells’. In: J Clin Invest. Augustus 2011; 121 (8): p. 3088–3093.

Arumugam, M. et al.: ‘Enterotypes of the Human Gut Microbiome’. In: Nature. 12 mei 2011; 474 (7353); 1: p. 174–180.

Bäckhed, F.: ‘Addressing the Gut Microbiome and Implications for Obesity’. In: International Dairy Journal. 2010; 20 (4): p. 259–261.

Balakrishnan, M., Floch, M.H.: ‘Prebiotics, Probiotics and Digestive Health’. In: Curr Opin Clin Nutr Metab Care. November 2012; 15 (6): p. 580–585.

Barros, F.C.: ‘Cesarean Section and Risk of Obesity in Childhood, Adolescence, and Early Adulthood: Evidence from 3 Brazilian Birth Cohorts’. In: Am J Clin Nutr. 2012; 95 (2): p. 465–70.

Bartolomeo, F. Di.: ‘Prebiotics to Fight Diseases: Reality or Fiction?’ In: Phytother Res. Oktober 2013; 27 (10): p. 1457–1473.

Bischoff, S.C., Köchling, K.: ‘Pro- und Präbiotika’. In: Zeitschrift für Stoffwechselforschung, klinische Ernährung und Diätik. 2012; 37: p. 287–304.

Borody, T.J. et al.: ‘Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions’. In: Curr Gastroenterol Rep. 2013; 15 (8): p. 337.

Bräunig, J.: Verbrauchertipps zu Lebensmittelhygiene, Reinigung und Desinfektion. Berlijn: Bundesinstitut für Risikobewertung, 2005.

Brede, C.: Das Instrument der Sauberkeit. Die Entwicklung der Massenproduktion von Feinseifen in Deutschland 1850 bis 2000. Münster et al.: Waxmann, 2005.

Bundesregierung: Antwort der Bundesregierung auf die Kleine Anfrage der Abgeordneten Friedrich Ostendorff, Bärbel Höhn, Nicole Maisch, weiterer Abgeordneter und der Fraktion BNDNIS 90/DIE GRNEN – Drucksache 17/10017. Daten zur Antibiotikavergabe in Nutztierhaltungen und zum Eintrag von Antibiotika und multiresistenten Keimen in die Umwelt. Drucksache 17/10313, 17 juli 2012, op http://dip21.bundestag.de/dip21/btd/17/103/1710313 (opgevraagd in oktober 2013).

Caporaso, J.G. et al.: ‘Moving Pictures of the Human Microbiome’. In: Genome Biol. 2011; 12 (5): p. R50.

Carvalho, B.M., Saad, M.J.: ‘Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance’. In: Mediators Inflamm. 2013: 986734.

Charalampopoulos, D., Rastall, R.A.: ‘Prebiotics in Foods’. In: Current Opinion in Biotechnology. 2012, 23 (2): p. 187–191.

Chen, Y. et al.: ‘Association Between Helicobacter Pylori and Mortality in the NHANES III Study’. In: Gut. September 2013; 62 (9): p. 1262–1269.

Devaraj, S. et al.: ‘The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes’. In: Clin Chem. April 2013; 59 (4): p. 617–628.

Dominguez-Bello, M.G. et al.: ‘Development of the Human Gastrointestinal Microbiota and Insights from High-throughput Sequencing’. In: Gastroenterology. Mei 2011; 140 (6): p. 1713–1719.

Douglas, L.C., Sanders, M.E.: ‘Probiotics and Prebiotics in Dietetics Practice’. In: J Am Diet Assoc. Maart 2008; 108 (3): p. 510–521.

Eppinger, M. et al.: ‘Who Ate Whom? Adaptive Helicobacter Genomic Changes That Accompanied a Host Jump from Early Humans to Large Felines’. In: PLoS Genet. Juli 2006; 2 (7): p. e120.

Fahey, J.W. et al.: ‘Urease from Helicobacter Pylori Is Inactivated by Sulforaphane and Other Isothiocyanates’. In: Biochem Biophys Res Commun. 24 mei 2013; 435 (1): p. 1–7.

Flegr, J.: ‘Influence of Latent Toxoplasma Infection on Human Personality, Physiology and Morphology: Pros and Cons of the Toxoplasma – Human Model in Studying the Manipulation Hypothesis’. In: J Exp Biol. 1 januari 2013; 216 (Pt. 1): p. 127–133.

Flegr, J. et al.: ‘Increased Incidence of Traffic Accidents in Toxoplasma-Infected Military Drivers and Protective Effect RhD Molecule Revealed by a Large-Scale Prospective Cohort Study’. In: BMC Infect Dis. 26 mei 2009; 9: p. 72.

Flint, H.J.: ‘Obesity and the Gut Microbiota’. In: J Clin Gastroenterol. November 2011; 45 (Suppl.): p. 128–132.

Fouhy, F. et al.: ‘High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin’. In: Antimicrob Agents Chemother. November 2012; 56 (11): p. 5811–5820.

Fuhrer, A. et al.: ‘Milk Sialyllactose Influences Colitis in Mice Through Selective Intestinal Bacterial Colonization’. In: J Exp Med. 20 december 2010; 207 (13): p. 2843–2854.

Gale, E.A.M.: ‘A Missing Link in the Hygiene Hypothesis?’ In: Diabetologia. 2002; 45 (4): p. 588–594.

Ganal, S.C. et al.: ‘Priming of Natural Killer Cells by Non-mucosal Mononuclear Phagocytes Requires Instructive Signals from the Commensal Microbiota’. In: Immunity. 27 juli 2012; 37 (1): p. 171–186.

Gibney, M.J., Burstyn, P.G.: ‘Milk, Serum Cholesterol, and the Maasai – A Hypothesis’. In: Atherosclerosis. 1980; 35 (3): p. 339–343.

Gleeson, M. et al.: ‘Daily Probiotic’s (Lactobacillus Sasei Shirota) Reduction of Infection Incidence in Athletes’. In: Int J Sport Nutr Exerc Metab. Februari 2011; 21 (1): p. 55–64.

Goldin, B.R., Gorbach, S.L.: ‘Clinical Indications for Probiotics: An Overview’. In: Clinical Infectious Diseases. 2008; 46 (Suppl. 2): p. S96–S100.

Gorkiewicz, G.: ‘Contribution of the Physiological Gut Microflora to Health and Disease’. In: J Gastroenterol Hepatol Erkr. 2009; 7 (1): p. 15–18.

Grewe, K.: Prävalenz von Salmonella ssp. in der primären Geflügelproduktion und Broilerschlachtung – Salmonelleneintrag bei Schlachtgeflügel während des Schlachtprozesses. Hannover: Tierärztliche Hochschule Hannover, 2011.

Guseo, A.: ‘The Parkinson Puzzle’. In: Orv Hetil. 30 december 2012; 153 (52): p. 2060–2069.

Herbarth, O. et al.: ‘Helicobacter Pylori Colonisation and Eczema’. In: Journal of Epidemiology and Community Health. 2007; 61 (7): p. 638–640.

Hullar, M.A., Lampe, J.W.: ‘The Gut Microbiome and Obesity’. In: Nestle Nutr Inst Workshop Ser. 2012; 73: p. 67–79.

Jernberg, C. et al.: ‘Long-Term Impacts of Antibiotic Exposure on the Human Intestinal Microbiota’. In: Microbiology. November 2010; 156 (Pt. 11): p. 3216–3223.

Jin, C., Flavell, R.A.: ‘Innate Sensors of Pathogen and Stress: Linking Inflammation to Obesity’. In: J Allergy Clin Immunol. Augustus 2013; 132 (2): p. 287–94.

Jirillo, E. et al.: ‘Healthy Effects Exerted by Prebiotics, Probiotics, and Symbiotics with Special Reference to Their Impact on the Immune System’. In: Int J Vitam Nutr Res. Juni 2012; 82 (3): p. 200–208.

Jones, M.L. et al.: ‘Cholesterol-Lowering Efficacy of a Microencapsulated Bile Salt Hydrolase-Active Lactobacillus Reuteri NCIMB 30242 Yoghurt Formulation in Hypercholesterolaemic Adults’. In: British Journal of Nutrition. 2012; 107 (10): p. 1505–1513.

Jumpertz, R. et al.: ‘Energy-Balance Studies Reveal Associations Between Gut Microbes, Caloric Load, and Nutrient Absorption in Humans’. In: Am J Clin Nutr. 2011; 94 (1): p. 58–65.

Katz, S.E.: The Art of Fermentation: An In-Depth Exploration of Essential Concepts and Processes from Around the World. Chelsea: Chelsea Green Publishing, 2012.

Katz, S.E.: Wild Fermentation: The Flavor, Nutrition, and Craft of Live-Culture Foods Reclaiming Domesticity from a Consumer Culture. Chelsea: Chelsea Green Publishing, 2011.

Kountouras, J. et al.: ‘Helicobacter Pylori Infection and Parkinson’s Disease: Apoptosis as an Underlying Common Contributor’. In: Eur J Neurol. Juni 2012; 19 (6): p. e56.

Krznarica, Željko et al.: ‘Gut Microbiota and Obesity’. In: Dig Dis. 2012; 30: p. 196–200.

Kumar, M. et al.: ‘Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases’. In: Exp Diabetes Res. 2012; 2012: 902917.

Macfarlane, G.T. et al.: ‘Bacterial Metabolism and Health-Related Effects of Galactooligosaccharides and Other Prebiotics’. In: J Appl Microbiol. Februari 2008; 104 (2): p. 305–344.

Mann, G.V. et al.: ‘Atherosclerosis in the Masai’. In: American Journal of Epidemiology. 1972; 95 (1): p. 26-37.

Marshall, B.J.: ‘Unidentified Curved Bacillus on Gastric Epithelium in Active Chronic Gastritis’. In: Lancet. 4 juni 1983; 1 (8336): p. 1273 ff.

Martinson, V.G. et al.: ‘A Simple and Distinctive Microbiota Associated with Honey Bees and Bumble Bees’. In: Mol Ecol. Februari 2011; 20 (3): p. 619–628.

Matamoros, S. et al.: ‘Development of Intestinal Microbiota in Infants and its Impact on Health’. In: Trends Microbiol. April 2013; 21 (4): p. 167–173.

Moodley, Y. et al.: ‘The Peopling of the Pacific from a Bacterial Perspective’. In: Science. 23 januari 2009; 323 (5913): p. 527–530.

Mori, K. et al.: ‘Does the Gut Microbiota Trigger Hashimoto’s Thyroiditis?’ In: Discov Med. November 2012; 14 (78): p. 321–326.

Musso, G. et al.: ‘Gut Microbiota as a Regulator of Energy Homeostasis and Ectopic Fat Deposition: Mechanisms and Implications for Metabolic Disorders’. In: Current Opinion in Lipidology. 2010; 21 (1): p. 76–83.

Nagpal, R. et al.: ‘Probiotics, their Health Benefits and Applications for Developing Healthier Foods: A Review’. In: FEMS Microbiol Lett. September 2012; 334 (1): p. 1–15.

Nakamura, Y.K., Omaye, S.T.: ‘Metabolic Diseases and Pro- and Prebiotics: Mechanistic Insights’. In: Nutr Metab (Lond). 19 juni 2012; 9 (1): p. 60.

Nicola, J.P. et al.: ‘Functional Toll-like Receptor 4 Conferring Lipopolysaccharide Responsiveness is Expressed in Thyroid Cells’. In: Endocrinology. Januari 2009; 150 (1): p. 500–508.

Nielsen, H.H. et al.: ‘Treatment for Helicobacter Pylori Infection and Risk of Parkinson’s Disease in Denmark’. In: Eur J Neurol. Juni 2012; 19 (6): p. 864–869.

Norris, V. et al.: ‘Bacteria Control Host Appetites’. In: J Bacteriol. Februari 2013; 195 (3): p. 411–416.

Okusaga, O., Postolache, T.T.: ‘Toxoplasma Gondii, the Immune System, and Suicidal Behavior’. In: Dwivedi, Y. (red.): The Neurobiological Basis of Suicide. Boca Raton, Florida: CRC Press, 2012: p. 159–194.

Ottman, N. et al.: ‘The Function of our Microbiota: Who Is Out There and What Do They Do?’ In: Front Cell Infect Microbiol. 9 augustus 2012; 2: p. 104.

Pavlolvíc, N. et al.: ‘Probiotics-Interactions with Bile Acids and Impact on Cholesterol Metabolism’. In: Appl Biochem Biotechnol. 2012; 168: p. 1880–1895.

Petrof, E.O. et al.: ‘Stool Substitute Transplant Therapy for the Eradication of Clostridium Difficile Infection: “RePOOPulating” the Gut’. In: Microbiome. 9 januari 2013; 1 (1): p. 3.

Reading, N.C., Kasper, D.L.: ‘The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis’. In: Front Microbiol. 7 juli 2011; 2: p. 148.

Roberfroid, M. et al.: ‘Prebiotic Effects: Metabolic and Health Benefits’. In: Br J Nutr. Augustus 2010; 104 (Suppl. 2): p. S1–S63.

Sanders, M.E. et al.: ‘An Update on the Use and Investigation of Probiotics in Health and Disease’. In: Gut. 2013; 62 (5): p. 787–796.

Sanza, Y. et al.: ‘Understanding the Role of Gut Microbes and Probiotics in Obesity: How Far Are We?’ In: Pharmacol Res. Maart 2013; 69 (1): p. 144–155.

Schmidt, C.: ‘The Startup Bugs’. In: Nat Biotechnol. April 2013; 31 (4): p. 279–281.

Scholz-Ahrens, K.E. et al.: ‘Prebiotics, Probiotics, and Synbiotics Affect Mineral Absorption, Bone Mineral Content, and Bone Structure’. In: J Nutr. Maart 2007; 137 (3 Suppl. 2): p. 838S–846S.

Schwarz, S. et al.: ‘Horizontal versus Familial Transmission of Helicobacter Pylori’. In: PLoS Pathog. Oktober 2008; 4 (10): p. e1000180.

Shen, J. et al.: ‘The Gut Microbiota, Obesity and Insulin Resistance’. In: Mol Aspects Med. Februari 2013; 34 (1): p. 39–58.

Starkenmann, C. et al.: ‘Olfactory Perception of Cysteine-S-Conjugates from Fruits and Vegetables’. In: J Agric Food Chem. 22 oktober 2008; 56 (20): p. 9575–9580.

Stowell, S.R. et al.: ‘Innate Immune Lectins Kill Bacteria Expressing Blood Group Antigen’. In: Nat Med. Maart 2010; 16 (3): p. 295–301.

Tängdén, T. et al.: ‘Foreign Travel Is a Major Risk Factor for Colonization with Escherichia Coli Producing CTX-M-Type Extended-Spectrum ß-Lactamases: A Prospective Study with Swedish Volunteers’. In: Antimicrob Agents Chemother. September 2010; 54 (9): p. 3564–3568.

Teixeira, T.F. et al.: ‘Potential Mechanisms for the Emerging Link Between Obesity and Increased Intestinal Permeability’. In: Nutr Res. September 2012; 32 (9): p. 637–647.

Torrey, E.F. et al.: ‘Antibodies to Toxoplasma Gondii in Patients With Schizophrenia: A Meta-Analysis’. In: Schizophr Bull. Mei 2007; 33 (3): p. 729–736.

Tremaroli, V., Bäckhed, F.: ‘Functional Interactions Between the Gut Microbiota and Host Metabolism.’ In: Nature. 13 september 2012; 489 (7415): p. 242–249.

Turnbaugh, P.J., Gordon, J.I.: ‘The Core Gut Microbiome, Energy Balance and Obesity’. In: J Physiol. 2009; 587 (17): p. 4153–4158.

Vrese, M. de; Schrezenmeir, J.: ‘Probiotics, Prebiotics, and Synbiotics’. In: Adv Biochem Engin/Biotechnol. 2008; 111: p. 1–66.

Vriese, J. de: ‘Medical Research. The Promise of Poop’. In: Science. 30 augustus 2013; 341 (6149): p. 954–957.

Vyas, U., Ranganathan, N.: ‘Probiotics, Prebiotics, and Synbiotics: Gut and Beyond’. In: Gastroenterol Res Pract. 2012: 872716.

Webster, J.P. et al.: ‘Effect of Toxoplasma Gondii upon Neophobic Behaviour in Wild Brown Rats, Rattus norvegicus’. In: Parasitology. Juli 1994; 109 (Pt. 1): p. 37–43.

Wichmann-Schauer, H.: Verbrauchertipps: Schutz vor Lebensmittelinfektionen im Privathaushalt. Berlijn: Bundesinstitut für Risikobewertung, 2007.

Wu, G.D. et al.: ‘Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes’. In: Science. 7 oktober 2011; 334 (6052): p. 105–108.

Yatsunenko, T. et al.: ‘Human Gut Microbiome Viewed Across Age and Geography’. In: Nature. 9 mei 2012; 486 (7402): p. 222–227.

Zipris, D.: ‘The Interplay Between the Gut Microbiota and the Immune System in the Mechanism of Type 1 Diabetes’. In: Curr Opin Endocrinol Diabetes Obes. Augustus 2013; 20 (4): p. 265–270.